Related Experiment Videos
New antibody approved for treatment of rheumatoid arthritis
1College of Pharmacy, University of Kentucky, Lexington, USA.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|April 12, 2003
Abstract:
Adalimumab joins free existing biologic agents for the treatment of RA. Its place among these therapeutic options is unclear until head-to-head studies are performed with adalimumab and other biologic DMARDs. Adalimumab is currently in clinical trials for additional therapeutic uses, namely Crohn's disease and coronary artery disease.